Reticular Skin Rash as an Adverse Effect of 5-Azacitidine

Azacitidine is a hypomethylating agent used for the treatment of patients with myelodysplastic syndrome (MDS). It has been approved by the Food and Drug Administration (FDA) and the European Medicines Agency for the treatment of MDS and is also indicated for the treatment of acute myeloid leukemia (...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Parul, Chandra, Usha, Shukla, Prakriti, Verma, Shailendra P, Suvirya, Swastika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117846/
https://www.ncbi.nlm.nih.gov/pubmed/35602804
http://dx.doi.org/10.7759/cureus.24228
_version_ 1784710399339266048
author Verma, Parul
Chandra, Usha
Shukla, Prakriti
Verma, Shailendra P
Suvirya, Swastika
author_facet Verma, Parul
Chandra, Usha
Shukla, Prakriti
Verma, Shailendra P
Suvirya, Swastika
author_sort Verma, Parul
collection PubMed
description Azacitidine is a hypomethylating agent used for the treatment of patients with myelodysplastic syndrome (MDS). It has been approved by the Food and Drug Administration (FDA) and the European Medicines Agency for the treatment of MDS and is also indicated for the treatment of acute myeloid leukemia (AML). Injection site erythema, ecchymosis, and petechiae are some of the common cutaneous adverse reactions associated with azacitidine. This article describes a rare adverse cutaneous drug reaction with azacitidine in the form of a reticular generalized skin rash in a 28-year-old female with AML.
format Online
Article
Text
id pubmed-9117846
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-91178462022-05-20 Reticular Skin Rash as an Adverse Effect of 5-Azacitidine Verma, Parul Chandra, Usha Shukla, Prakriti Verma, Shailendra P Suvirya, Swastika Cureus Dermatology Azacitidine is a hypomethylating agent used for the treatment of patients with myelodysplastic syndrome (MDS). It has been approved by the Food and Drug Administration (FDA) and the European Medicines Agency for the treatment of MDS and is also indicated for the treatment of acute myeloid leukemia (AML). Injection site erythema, ecchymosis, and petechiae are some of the common cutaneous adverse reactions associated with azacitidine. This article describes a rare adverse cutaneous drug reaction with azacitidine in the form of a reticular generalized skin rash in a 28-year-old female with AML. Cureus 2022-04-18 /pmc/articles/PMC9117846/ /pubmed/35602804 http://dx.doi.org/10.7759/cureus.24228 Text en Copyright © 2022, Verma et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Verma, Parul
Chandra, Usha
Shukla, Prakriti
Verma, Shailendra P
Suvirya, Swastika
Reticular Skin Rash as an Adverse Effect of 5-Azacitidine
title Reticular Skin Rash as an Adverse Effect of 5-Azacitidine
title_full Reticular Skin Rash as an Adverse Effect of 5-Azacitidine
title_fullStr Reticular Skin Rash as an Adverse Effect of 5-Azacitidine
title_full_unstemmed Reticular Skin Rash as an Adverse Effect of 5-Azacitidine
title_short Reticular Skin Rash as an Adverse Effect of 5-Azacitidine
title_sort reticular skin rash as an adverse effect of 5-azacitidine
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117846/
https://www.ncbi.nlm.nih.gov/pubmed/35602804
http://dx.doi.org/10.7759/cureus.24228
work_keys_str_mv AT vermaparul reticularskinrashasanadverseeffectof5azacitidine
AT chandrausha reticularskinrashasanadverseeffectof5azacitidine
AT shuklaprakriti reticularskinrashasanadverseeffectof5azacitidine
AT vermashailendrap reticularskinrashasanadverseeffectof5azacitidine
AT suviryaswastika reticularskinrashasanadverseeffectof5azacitidine

Ejemplares similares